BÜHLMANN Laboratories AG appoints Eric Hrimech as global Chief Commercial Officer (CCO) - BÜHLMANN Laboratories AG today announced the appointment of Eric Hrimech to the newly created position of global Chief Commercial Officer (CCO).
BÜHLMANN Laboratories AG appoints Christian Eberle as CEO - BÜHLMANN Laboratories AG announced the appointment of Christian Eberle as its new CEO.
Brandenburg Gate in Berlin, Germany, with clear blue skies, representing the location of ECCO 2025, held from February 20-22. Event branding with the BÜHLMANN logo is displayed. ECCO 2025 – Thank you for visiting us! - Thanks for connecting with us at ECCO 2025 in Berlin! We enjoyed discussing how IBDoc® and Quantum Blue® are advancing IBD care.

CNBH 2025

Date: 23 – 24 January 2025
Location: Paris, France

Journées Nationales du Collège National de Biochimie des Hôpitaux.

MEDLAB Middle East 2025

Date: 3 – 6 February 2025
Location: Dubai, U.A.E.

MEDLAB Middle East 2025. Visit our booth #Z4.J16.

CCC 2025

Date: 6 – 8 February 2025
Location: San Francisco, CA, USA

Crohn’s & Colitis Congress.

ECCO 2025

Date: 19 – 22 February 2025
Location: Berlin, Germany

Inflammatory Bowel Diseases – 20th Congress of ECCO. Visit our booth #8 in hall 2.2.